Details for New Drug Application (NDA): 206261
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 206261
Tradename: | ACYCLOVIR |
Applicant: | Carlsbad Technology |
Ingredient: | acyclovir |
Patents: | 0 |
Pharmacology for NDA: 206261
Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 206261
Suppliers and Packaging for NDA: 206261
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACYCLOVIR | acyclovir | CAPSULE;ORAL | 206261 | ANDA | Golden State Medical Supply, Inc. | 51407-852 | 51407-852-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (51407-852-01) |
ACYCLOVIR | acyclovir | CAPSULE;ORAL | 206261 | ANDA | Golden State Medical Supply, Inc. | 51407-852 | 51407-852-05 | 500 CAPSULE in 1 BOTTLE, PLASTIC (51407-852-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Aug 16, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription